Interactive explainers mapping how medicines move from first molecule to market — and where the opportunities and attrition lie along the way.
Walk a candidate through development, stage by stage.
Discovery → IND. A shared-timeline Gantt and candidate-attrition funnel across three modalities, told for students, investors, and scientists.
Open tutorialPhase 1 → approval. Trial design, endpoints, attrition, and regulatory milestones from first-in-human to NDA/BLA.
Explore indications by their therapeutic landscape — approved and clinical-phase drugs mapped by target, modality, and development stage.
Weigh indications as investments — unmet need, market size, competitive density, and probability of success in one view.